CLOs on the Move

SimpleHealth

www.simplehealth.com

 
SimpleHealth Founded in 2018 and based in New York City, SimpleHealth makes reproductive wellness simple! Operating in 32 states and growing, SimpleHealth is a nationally recognized telehealth provider of reproductive wellness, offering birth control, herpes and cold sore treatment, and over-the-counter supplements` SimpleHealth`s mission is to be the #1 reproductive wellness provider, giving access to those who otherwise wouldn`t be able to find reproductive care in a convenient and affordable way`
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Ashley Antler
Vice President of Legal and Head of Regulatory Affairs Profile

Similar Companies

BurnAlong

Get in shape, build strength, tone, and lose weight, faster with BurnAlong.

Amkai

Amkai is a Armonk, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Catabasis

At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART LinkerSM platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.

Columbine Care Ctr East

Columbine Care Ctr East is a Fort Collins, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alector

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.